{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "65-year-old man referred to hospital with suspected uveitis of the right eye, experiencing right ocular pain and blurred vision 1 month prior to presentation.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "65-year-old man with right ocular pain and blurred vision",
              "duration": "1 month",
              "onset": "1 month prior to presentation",
              "associated_symptoms": [
                "blurred vision"
              ],
              "exacerbating_factors": [
                "right ocular pain"
              ]
            }
          ],
          "diagnoses": [
            {
              "code": "C0042095",
              "label": "Uveitis",
              "status": "suspected",
              "onset_date": null
            }
          ]
        }
      },
      "custom_id": "graph_058_N0"
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Diagnosed with small cell lung cancer (SCLC) (cT4N3M1c) with right cerebellar metastasis and invasion 4 months prior to presentation.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0007106",
              "label": "Small cell lung cancer",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C0242393",
              "label": "Metastasis",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      },
      "custom_id": "graph_058_N1"
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Started therapy with topical 0.005% latanoprost, 1.0% brinzolamide, 0.5% timolol maleate, and oral acetazolamide at a dose of 500 mg/day.",
        "clinical_data": {
          "medications": [
            {
              "drug": "latanoprost",
              "dosage": "0.005%",
              "frequency": null,
              "modality": "topical",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "brinzolamide",
              "dosage": "1.0%",
              "frequency": null,
              "modality": "topical",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "timolol maleate",
              "dosage": "0.5%",
              "frequency": null,
              "modality": "topical",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "acetazolamide",
              "dosage": "500 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      },
      "custom_id": "graph_058_N2"
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Required intravenous administration of 200 mL of 20% hypertonic mannitol every 2-3 days, for a total of five administrations due to high IOP and pronounced nausea.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0024862",
              "dosage": "200 mL",
              "frequency": "every 2-3 days",
              "modality": "IV",
              "indication": "C0022108"
            }
          ]
        }
      },
      "custom_id": "graph_058_N3"
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Anterior chamber fluid cytology revealed iris metastasis from SCLC, consistent with bronchoalveolar lavage cytology results. This occurred 10 days after the initial visit.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0346645",
              "label": "Metastasis to iris",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C0007107",
              "label": "Bronchoalveolar Lavage",
              "status": "active",
              "onset_date": null
            }
          ],
          "labs": [
            {
              "test": "C0010520",
              "value": "positive",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      },
      "custom_id": "graph_058_N4"
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Received a single intravitreal injection of 2 mg (0.05 mL of 40 mg/mL) aflibercept OD to treat the neovascular glaucoma 10 days after initial visit.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C3258542",
              "dosage": "2 mg (0.05 mL of 40 mg/mL)",
              "frequency": "single",
              "modality": "IV",
              "indication": "C0271198"
            }
          ],
          "procedures": [
            {
              "name": "intravitreal injection",
              "date": "null",
              "location": "OD"
            }
          ],
          "diagnoses": [
            {
              "code": "C0271198",
              "label": "Neovascular Glaucoma",
              "status": "active",
              "onset_date": "null"
            }
          ]
        }
      },
      "custom_id": "graph_058_N5"
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Five days post-aflibercept injection: iris tumor size and iris neovascularization decreased; IOP measured at 18 mm Hg. Antiglaucoma medications continued to maintain IOP. Intravenous hypertonic mannitol no longer required; ocular pain and nausea relieved.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705477",
              "indication": "C0017624"
            }
          ],
          "procedures": [
            {
              "name": "C4025443",
              "date": null,
              "outcome": "decreased"
            }
          ],
          "vitals": [
            {
              "type": "C0020239",
              "value": "18",
              "unit": "mm Hg"
            }
          ],
          "diagnoses": [
            {
              "code": "C0027453",
              "label": "Nausea",
              "status": "resolved"
            },
            {
              "code": "C0032288",
              "label": "Pain",
              "status": "resolved"
            }
          ]
        }
      },
      "custom_id": "graph_058_N6"
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient was diagnosed with small cell lung cancer (SCLC) (cT4N3M1c) with right cerebellar metastasis and invasion 4 months prior to presentation, after presenting with suspected uveitis."
      },
      "custom_id": "graph_058_N1_N2"
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Initiation of topical 0.005% latanoprost, 1.0% brinzolamide, 0.5% timolol maleate, and oral acetazolamide at a dose of 500 mg/day following SCLC diagnosis.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0023274",
            "C0587438",
            "C0587472",
            "C0001372"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_058_N2_N3"
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Patient required intravenous administration of 200 mL of 20% hypertonic mannitol every 2-3 days, for a total of five administrations due to high IOP and pronounced nausea.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0022108",
            "C0027453"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      },
      "custom_id": "graph_058_N3_N4"
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Anterior chamber fluid cytology revealed iris metastasis from SCLC, consistent with bronchoalveolar lavage cytology results. This occurred 10 days after the initial visit.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0010520",
            "C0346645"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      },
      "custom_id": "graph_058_N4_N5"
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Received a single intravitreal injection of 2 mg (0.05 mL of 40 mg/mL) aflibercept OD to treat the neovascular glaucoma 10 days after initial visit.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C3258542"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      },
      "custom_id": "graph_058_N5_N6"
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Five days post-aflibercept injection: iris tumor size and iris neovascularization decreased; IOP measured at 18 mm Hg. Antiglaucoma medications continued to maintain IOP. Intravenous hypertonic mannitol no longer required; ocular pain and nausea relieved.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0024862"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_058_N6_N7"
    }
  ]
}